Loading clinical trials...

Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 1NCT06752486

Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study

The current study aims at assessing the efficacy and safety of oral Gabapentin alone versus Diclofenac Potassium drugs for postoperative analgesia in patients undergoing surface ablation.

Lead sponsor: Research Institute of Ophthalmology, Egypt•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Dina Moustafa M Ali, MD

CONTACT

01113981021 dina.moustafa.ali@gmail.com

Mohamed Tarek Ahmed El- Naggar, MD- FRCS

CONTACT

01222158593 drtarekelnaggar@hotmail.com

Trial snapshot

StatusRECRUITING

PhasePHASE1

Enrollment64

Start dateDec 2024

Last updatedApr 30, 2025

Condition

Pain After Photorefractive Keratectomy VAS Will be Used to Assess Pain Postoperative

Locations shown

Research Institute of Ophthalmolgy

Giza

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 30, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions